Loading insider details...
Beta
Latest Form 4 (Mar 23, 2026): Conversion of 66,667 CRIS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 23, 2026 | CURIS INC (CRIS) | Conversion | 66,667 | n/a |
| Mar 18, 2026 | CURIS INC (CRIS) | Grant/Award | 50 | n/a |
| May 5, 2025 | CURIS INC (CRIS) | Grant/Award | 200,000 | $496.0K |
| Aug 14, 2024 | Vincerx Pharma, Inc. (VINC) | Disposition to Issuer | 127,500 | n/a |
| May 29, 2024 | Vincerx Pharma, Inc. (VINC) | Grant/Award | 53,254 | n/a |
| Mar 8, 2024 | Vincerx Pharma, Inc. (VINC) | Grant/Award | 146,746 | n/a |
| Aug 10, 2023 | Vincerx Pharma, Inc. (VINC) | Purchase | 16,900 | $16.0K |
| Feb 16, 2023 | Vincerx Pharma, Inc. (VINC) | Grant/Award | 90,000 | n/a |
| Dec 14, 2022 | Vincerx Pharma, Inc. (VINC) | Purchase | 35,280 | $30.5K |
| Nov 17, 2022 | Vincerx Pharma, Inc. (VINC) | Grant/Award | 60,000 | n/a |